1. Home
  2. CYCC vs LUCY Comparison

CYCC vs LUCY Comparison

Compare CYCC & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • LUCY
  • Stock Information
  • Founded
  • CYCC 1992
  • LUCY 2017
  • Country
  • CYCC Malaysia
  • LUCY United States
  • Employees
  • CYCC N/A
  • LUCY N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • LUCY Ophthalmic Goods
  • Sector
  • CYCC Health Care
  • LUCY Health Care
  • Exchange
  • CYCC Nasdaq
  • LUCY Nasdaq
  • Market Cap
  • CYCC 7.8M
  • LUCY 8.9M
  • IPO Year
  • CYCC N/A
  • LUCY 2022
  • Fundamental
  • Price
  • CYCC $16.04
  • LUCY $2.13
  • Analyst Decision
  • CYCC
  • LUCY
  • Analyst Count
  • CYCC 0
  • LUCY 0
  • Target Price
  • CYCC N/A
  • LUCY N/A
  • AVG Volume (30 Days)
  • CYCC 5.3M
  • LUCY 305.9K
  • Earning Date
  • CYCC 08-13-2025
  • LUCY 08-11-2025
  • Dividend Yield
  • CYCC N/A
  • LUCY N/A
  • EPS Growth
  • CYCC N/A
  • LUCY N/A
  • EPS
  • CYCC N/A
  • LUCY N/A
  • Revenue
  • CYCC $14,000.00
  • LUCY $1,707,470.00
  • Revenue This Year
  • CYCC $137.21
  • LUCY $367.48
  • Revenue Next Year
  • CYCC N/A
  • LUCY $166.67
  • P/E Ratio
  • CYCC N/A
  • LUCY N/A
  • Revenue Growth
  • CYCC N/A
  • LUCY 22.75
  • 52 Week Low
  • CYCC $3.08
  • LUCY $1.57
  • 52 Week High
  • CYCC $597.60
  • LUCY $11.16
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 60.33
  • LUCY 45.27
  • Support Level
  • CYCC $10.05
  • LUCY $2.07
  • Resistance Level
  • CYCC $19.87
  • LUCY $2.26
  • Average True Range (ATR)
  • CYCC 3.57
  • LUCY 0.12
  • MACD
  • CYCC 1.99
  • LUCY 0.02
  • Stochastic Oscillator
  • CYCC 77.07
  • LUCY 31.58

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.

About LUCY Innovative Eyewear Inc.

Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.

Share on Social Networks: